nejm semaglutide heart failure Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Anti-obesity medications in the management

They represent a new chapter in the gradual conceptual shift in how society approaches obesity from a lifestyle condition to a complex, preventable and treatable chronic disease, its statement in the Journal of the American Medical Association said

And many insurers requirements that patients receive prior authorization or first try less expensive drugs add to delays in care

BPC-157 could heal muscle injuries In a 2006 study, Croatian researchers cut up the quadriceps muscle in rats in a way where healing was previously believed to be impossible

Most people with prediabetes who progress to diabetes will eventually develop cardiovascular complications

Exposure to the riboflavin analog roseoflavin isolated from Streptomyces davawensis was found to lead B

Exenatide immediate-release requires taking oral contraceptives at least 1 hour before administration